Replies to post #90277 on Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

The damage has already been done, as ADXS has very few options at this point. Companies like ADXS die a slow death. If shareholders vote no, they will lose 100% rather than the 90% already gone, so the cycle continues and management will continue to collect compensation as long as they can keep the doors open. This round of financing will not be from investors, as ADXS already burnt that bridge, but from toxic finances. Remaining retail shareholders will continue to blame everybody but themselves for making a bad investment decision.

[fbg0316]

Looking back over the last two years, it's clear now no pharma has been impressed enough with ADXS trial data to put money in the company. I held out hope until Agmen lost confidence in the viability of the platform and bailed. Without any BP endorsing ADXS as a late stage company, why would any rationale imvestor put more money in the company. We are seeing the wind down now.